Francisco Durazo, MD, FACP

Request an Appointment

Location

Gastroenterology and Hepatology - Froedtert Hospital
9200 West Wisconsin Avenue
Milwaukee, WI 53226

Specialties

Gastroenterology
Transplant Hepatology

New & Established Patients Call

(414) 805-6633

Overview

Diseases and Conditions

Autoimmune Hepatitis
Cirrhosis
Hepatic Encephalopathy
Hepatitis
Liver Cancer
Liver Tumors
End-Stage Liver Disease
Hepatocellular Carcinoma
Fatty Liver Disease
Alcoholic Hepatitis

Treatments and Services

Endoscopy
Liver Transplant Evaluation and Management
Liver Transplantation
Hepatology
Post-Liver Transplantation Care

Patients Ages Seen

Adolescent
Adult
Senior

Languages

English
Spanish

Hospital Affiliations

Froedtert Hospital – Milwaukee

Board Certifications

Gastroenterology
Internal Medicine
Transplant Hepatology

Clinic Locations

Gastroenterology and Hepatology - Froedtert Hospital

9200 West Wisconsin Avenue
Milwaukee, WI 53226
(414) 805-3310
Get Directions

Biography

Dr. Durazo specializes in diseases of the liver with a focus on the treatment of hepatocellular carcinoma, drug induced liver injury and non-alcoholic fatty liver disease. Dr. Durazo is also active in clinical research focused on diseases of the liver. Additionally, he is an active presenter at national and international meetings, a fellow of the American College of Physicians and a fellow of the American Association for the Study of Liver Diseases.

Education and Training

Doctor of Medicine - State of Mexico University - Mexico City (1981)
Internship - American British Cowdray Hospital - Ciudad de México (1979-1980)
Internship in Internal Medicine - University of Southern California - Los Angeles, CA (1986-1987)
Residency in Internal Medicine - University of Southern California - Los Angeles, CA (1987-1989)
Chief Resident - Internal Medicine - University of Southern California - Los Angeles, CA (1989-1990)
Fellowship in Gastroenterology and Liver Diseases - University of Southern California - Los Angeles, CA (1990-1992)

Long-term outcomes with oral therapy in liver transplant recipients with hepatitis B.

(Saab S, Song D, Challita YP, Xiwen Zhou T, Saab EG, Viramontes MR, Choi G, Durazo FA, Han SB, El Kabany MM, Jackson NJ, Busuttil RW.) Clin Transplant. 2019 Dec;33(12):e13740 PMID: 31651048 10/28/2019
Elimination of Hepatitis C in Liver Transplant Recipients.

(Saab S, Challita Y, Chen PH, Jimenez MA, Lee AD, Saab EG, Ahn T, Choi G, Durazo FA, El-Kabany MM, Han SB, Grotts J, Agopian VG, Busuttil RW.) J Clin Transl Hepatol. 2018 Sep 28;6(3):247-250 PMID: 30271735 PMCID: PMC6160303 10/03/2018
Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients.

(Saab S, Barnard A, Challita Y, Adeniyi A, Aziz A, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW.) Exp Clin Transplant. 2018 08;16(4):419-424 PMID: 30060729 08/01/2018
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.

(Saab S, Rheem J, Jimenez MA, Fong TM, Mai MH, Kachadoorian CA, Esmailzadeh NL, Bau SN, Kang S, Ramirez SD, Grotts J, Choi G, Durazo FA, El-Kabany MM, Han SB, Busuttil RW.) J Clin Transl Hepatol. 2017 Jun 28;5(2):101-108 PMID: 28660147 PMCID: PMC5472930 07/01/2017
Decrease of Alpha-fetoprotein in Patients with Cirrhosis Treated with Direct-acting Antivirals.

(Nguyen K, Jimenez M, Moghadam N, Wu C, Farid A, Grotts J, Elashoff D, Choi G, Durazo FA, El-Kabany MM, Han SB, Saab S.) J Clin Transl Hepatol. 2017 Mar 28;5(1):43-49 PMID: 28507926 PMCID: PMC5411356 05/17/2017
Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on Hemodialysis.

(Saab S, A Jimenez M, N Bau S, Choi G, Durazo FA, M El-Kabany M, Han SB, Busuttil RW.) J Clin Gastroenterol. 2017 Feb;51(2):167-173 PMID: 27548734 08/23/2016
Limited Knowledge of Acetaminophen in Patients with Liver Disease.

(Saab S, Konyn PG, Viramontes MR, Jimenez MA, Grotts JF, Hamidzadah W, Dang VP, Esmailzadeh NL, Choi G, Durazo FA, El-Kabany MM, Han SB, Tong MJ.) J Clin Transl Hepatol. 2016 Dec 28;4(4):281-287 PMID: 28097095 PMCID: PMC5225146 01/18/2017
Intraductal Cooling via a Nasobiliary Tube During Radiofrequency Ablation of Central Liver Tumors Reduces Biliary Injuries.

(Felker ER, Lee-Felker SA, Ajwichai K, Tan N, Lu DS, Durazo FA, Raman SS.) AJR Am J Roentgenol. 2015 Jun;204(6):1329-35 PMID: 26001245 05/23/2015
Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma: a 24-year experience in a single center.

(Hong JC, Jones CM, Duffy JP, Petrowsky H, Farmer DG, French S, Finn R, Durazo FA, Saab S, Tong MJ, Hiatt JR, Busuttil RW.) Arch Surg. 2011 Jun;146(6):683-9 PMID: 21690444 SCOPUS ID: 2-s2.0-79959342683 06/22/2011
Predictive index for tumor recurrence after liver transplantation for locally advanced intrahepatic and hilar cholangiocarcinoma.

(Hong JC, Petrowsky H, Kaldas FM, Farmer DG, Durazo FA, Finn RS, Saab S, Han SH, Lee P, Markovic D, Lassman C, Hiatt JR, Busuttil RW.) J Am Coll Surg. 2011 Apr;212(4):514-20; discussion 520-1 PMID: 21463781 SCOPUS ID: 2-s2.0-79953784805 04/06/2011
Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?

(Tabibian JH, Lazo M, Durazo FA, Yeh HC, Tong MJ, Clark JM.) J Gastroenterol Hepatol. 2011 Mar;26(3):501-9 PMID: 21332546 PMCID: PMC4937792 02/22/2011
A proposed, evidence-based approach to the treatment of chronic Hepatitis B.

(Han SH, Durazo FA, Saab S, Tong MJ.) J Clin Gastroenterol. 2011 Mar;45(3):259-66 PMID: 20856136 09/22/2010